ReviewCellular and molecular neurobiology2026
Decoding Alzheimer's Disease One Cell Class at a Time.
Review in Cellular and molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Multimodal imaging-based on single-cell genomics and spatial transcriptomics has shed new light on the taxonomy of genetically defined cell clusters in the mammalian brain. While transcriptomic approaches have revolutionized our ability to classify brain cells, their true value emerges when they are interpreted in conjunction with anatomical, physiological, and translational frameworks. Accordingly, significant progress has been made to elucidate relationships between gene expression, electrical and morphological properties of some of these clusters. This rapidly growing body of work shows not only that the cell cluster composition varies across brain regions but also evolves over time and changes during the progression of disease states like Alzheimer's disease. Given this complexity, integrating transcriptomic, structural, and functional data is now becoming essential for drawing meaningful comparisons across studies. In this review, we summarize these findings and discuss how this knowledge base is shifting towards more integrative approaches, quickly challenging current ideas regarding the genetic, molecular, and cellular underpinnings of Alzheimer's disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.